Compound information
- Natural Products
- ZC1261960
- Molecular Formula
- C20H22N2O6S
- Molecular Weight
- 418.119857424 g/mol
- Structure
-
- IUPAC Name
- phenyl 4-(4-ethoxycarbonylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C20H22N2O6S/c1-2-27-19(23)16-8-10-18(11-9-16)29(25,26)22-14-12-21(13-15-22)20(24)28-17-6-4-3-5-7-17/h3-11H,2,12-15H2,1H3
- InChI Key
- QDJCZYZAPCREOQ-UHFFFAOYSA-N
- SMILES
- CCOC(=O)c1ccc(S(=O)(=O)N2CCN(C(=O)Oc3ccccc3)CC2)cc1
- Source
- ZINC000040160263
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 29 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 93.22 Å2 | LogP | 3.126 |
LogS | -4.528 | LogD | 3.531 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.027 | Pgp substrate | 0.022 |
HIA | 0.965 | F20 % | 0.137 |
F30 % | 0.53 | Caco-2 | -4.46 |
MDCK | -4.685 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.054 | PPB | 77.743 |
VD | 1.144 | Fu | 1.528 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.127 | CYP1A2 substrate | 0.539 |
CYP2A6 substrate | 0.572 | CYP2B6 substrate | 0.681 |
CYP2C19 inhibitor | 0.755 | CYP2C19 substrate | 0.735 |
CYP2C8 substrate | 0.585 | CYP2C9 inhibitor | 0.99 |
CYP2C9 substrate | 0.996 | CYP2D6 inhibitor | 0.108 |
CYP2D6 substrate | 0.456 | CYP2E1 substrate | 0.62 |
CYP3A4 inhibitor | 0.072 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.703 | CL | 4.362 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.541 | Hepatotoxicity | 0.191 |
Mutagenicity | 0.032 | Rat Oral Acute Toxicity | 0.252 |
FDAMDD | 0.15 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.056 | Eye Corrosion | 0.001 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.016 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.745 | IGC50 | 4.136 |
LC50FM | 2.577 | LC50DM | 0.577 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.212 | NR-AR-LBD | 0.398 |
NR-AhR | 0.079 | NR-Aromatase | 0.026 |
NR-ER | 0.471 | NR-ER-LBD | 0.473 |
NR-PPAR-gamma | 0.126 | SR-ARE | 0.552 |
SR-ATAD5 | 0.333 | SR-HSE | 0.107 |
SR-MMP | 0.04 | SR-p53 | 0.038 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.